Management of Oral Disease in the 21st Century
Date:
Tuesday September 14th, 2010
Location:
Prosthodontic Associates Centre for Excellence - 2300 Yonge Street, # 901
A powerful evidence based lecture empowering today’s dental professional to effectively address caries prevention and dentinal hypersensitivity. As today’s dental client ages and retains their natural ...
Novel Approaches to the Management of Periodontitis SOLD OUT
Download Course in PDF format
Download Course in PDF format
Course Description
Overview - Describe the pathophysiology of periodontitis in order to identify mechanisms of disease that can now be targeted in order to effect either a cure or at least to control disease progression. - Discuss the use of systemic and locally applied antimicrobial medications for management of newly arising and in particular rebound chronic periodontitis. This will also include information pertaining to a newly emerging therapeutic, photodynamic therapy (PDT) and lasers. - Educate the participants in regard to novel management approaches that can be used for modulation of the host-regulated periodontal disease processes which include downregulation of matrix metalloprotease (collagenase) activity as well as inhibition of bone resorption and reductions in inflammation. Time permitting approaches to management of periodontitis in smokers will also be addressed.
Speaker
Dr. Howard Tenenbaum
Dr. Tenenbaum received his D.D.S. from the University of Toronto in 1978 and then completed his specialty in Periodontology as well as a Ph.D. in bone cell biology by 1982. This was followed by a 2-year post-doctoral MRC fellowship in Bethesda at the National Institutes of Health. In addition to his degrees, Dr. Tenenbaum has a Fellowship from the Royal College of Dentists of Canada, as well as the International College of Dentists and the Academy of Dentistry International. Dr. Tenenbaum is a Professor of Periodontology, and was Head of that Discipline for 8 years (1997-2005), at the Faculty of Dentistry, University of Toronto. He is a cross-appointed Professor in the Department of Laboratory Medicine and Pathophysiology, Faculty of Medicine, University of Toronto and is the Head of the Division of Research in the Department of Dentistry at Mount Sinai Hospital. Dr. Tenenbaum also serves as an FDA panel member for Dental Devices and Drugs (USA) and is Vice-Chair of the Federal Dental Care Advisory Committee (Canada).
Date
Tuesday April 20th, 2010
6:00pm - 9:00pm
Tuition
$65.00 plus GST
Location
Prosthodontic Associates Centre for Excellence - 2300 Yonge Street, # 901
Register
www.paceeducation.ca or 1.877.920.PACE(7223)
Prosthodontic Associates